374 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ACN Accenture plc $171.04 $109.71B N/A
Article Searches
What to Watch When Cognizant Reports Q2 Results https://www.fool.com/investing/2017/08/02/what-to-watch-when-cognizant-reports-q2-results.aspx?source=iedfolrf0000001 Aug 02, 2017 - Operating margin plus results at a critical business segment will be the highlights of the quarter.
Biotech Sebacia scores $26M in venture capital to treat acne http://feeds.bizjournals.com/~r/industry_6/~3/Ij5WZ1_JUm4/biotech-sebacia-scores-26m-in-venture-capital-to.html Jul 28, 2017 - Sebacia Inc., which is based in Duluth, Ga., is developing a topical formulation that uses laser-activated microparticles to treat moderate to severe acne. Sebacia intends to use the Series D financing to complete a U.S. pivotal trial.
3 Ways to Earn a Promotion https://www.fool.com/careers/2017/07/18/3-ways-to-earn-a-promotion.aspx?source=iedfolrf0000001 Jul 18, 2017 - Sometimes getting ahead requires a little extra effort.
Better Buy: Global Payments vs. Square https://www.fool.com/investing/2017/07/14/better-buy-global-payments-vs-square.aspx?source=iedfolrf0000001 Jul 14, 2017 - Which of these payment processing companies offers investors the best way to capitalize on the rise of digital and electronic payments?
Is the Market Giving Cognizant a Pass? https://www.fool.com/investing/2017/07/12/is-the-market-giving-cognizant-a-pass.aspx?source=iedfolrf0000001 Jul 12, 2017 - Accenture is beginning to feel the effects of uncertainty around healthcare legislation. Is Cognizant next?
3 Risks Facing Accenture Plc https://www.fool.com/investing/2017/07/11/3-risks-facing-accenture-plc.aspx?source=iedfolrf0000001 Jul 11, 2017 - Shares haven't kept up with the market this year. Here are three risks that could keep the IT consultant from catching up.
As it pushes forward with its acne drug, Novan's cash dwindles to $30 million http://feeds.bizjournals.com/~r/industry_6/~3/1lsifAAEpg0/as-it-pushes-forward-with-itsacne-drug-novans-cash.html Jul 07, 2017 - With cash dwindling, Morrisville-based Novan (Nasdaq: NOVN) is continuing to push forward with its nitric-oxide based acne product SB204 on the heels of a leadership change and workforce reduction. Earlier this year, the company announced mixed Phase 3 clinical trial results for SB204, which sent its stock plummeting 75 percent. Shortly thereafter, Novan said it had assembled a team to analyze the data from those trials and that it continues to remain optimistic on the product and a pre-submission…
Accenture Acquires Intrepid to Boost Digital Design Services http://www.zacks.com/stock/news/266001/accenture-acquires-intrepid-to-boost-digital-design-services?cid=CS-ZC-FT-266001 Jun 29, 2017 - In an effort to further enhance its digital design services, Accenture Plc (ACN) recently acquired Cambridge-based mobile design and development company ??? Intrepid.
Instant Analysis: Accenture Transferring $1.6 Billion in Pension Liabilities https://www.fool.com/investing/2017/06/27/instant-analysis-accenture-transferring-16-billion.aspx?source=iedfolrf0000001 Jun 27, 2017 - Accenture will eliminate its existing U.S. pension plan with lump-sum payments and group annuity contracts.
3 Value Stocks for Successful Investors https://www.fool.com/investing/2017/06/25/3-value-stocks-for-successful-investors.aspx?source=iedfolrf0000001 Jun 25, 2017 - It is said that success breeds success. Here are three companies that have proved to be best-of-breed, but their stocks are undervalued. Successful investors should take note.

Pages: 1...2526272829303132333435...38

<<<Page 30>